You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

 

Online download statistics by month:

Online download statistics by month: April 2022 to November 2024

AbstractFullPdf
Apr 2022534557180
May 2022266277144
Jun 202213914252
Jul 202211311842
Aug 202215516541
Sep 202210110643
Oct 202211512541
Nov 20229910039
Dec 2022919258
Jan 2023768044
Feb 2023838346
Mar 2023556147
Apr 2023242725
May 2023565730
Jun 2023525215
Jul 2023464730
Aug 202325278
Sep 2023383824
Oct 2023353627
Nov 2023484825
Dec 2023363725
Jan 2024484930
Feb 2024313123
Mar 2024525279
Apr 2024434436
May 2024747437
Jun 2024505025
Jul 2024535422
Aug 2024353633
Sep 2024474930
Oct 2024515540
Nov 2024464728
Total271728161369